On the Record · Insulet
Insulet competitors, on the record
The companies Insulet names as competitors in its annual reports, 2023 to 2025, and the companies that name Insulet, each with the sentence and the filing.
Who Insulet names
| Company | Named in |
|---|---|
| Beta Bionics Inc. | 2025 |
| Medtronic Diabetes, a division of Medtronic plc | 2025 |
| Tandem Diabetes Care Inc. | 2025 |
In its own words
Beta Bionics Inc., Medtronic Diabetes, a division of Medtronic plc, Tandem Diabetes Care Inc.
Word for word“We compete with established companies that produce insulin pumps, such as Medtronic Diabetes, a division of Medtronic plc (which division is being spun out into a new, independent publicly traded company), Tandem Diabetes Care Inc., as well as emerging companies like Beta Bionics Inc.” 10-K for 2025
Who names Insulet
Companies whose own annual reports name Insulet as a competitor.
Word for word“We compete with companies such as Beta Bionics, Inc.; Dexcom, Inc.; Insulet Corporation; Sequel Med Tech, LLC; and Tandem Diabetes Care, Inc.” 10-K for 2026
Word for word“Our primary competitors are major medical device companies, primarily Beta Bionics, Insulet, Medtronic, mylife (formerly Ypsomed) and Sequel.” 10-K for 2025
Read from Insulet’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.